Gen-M injection 60mg

About Gen-M injection 60mg

Gen-M Injection 60mg Uses

• Treatment of severe and complicated malaria
• Management of cerebral malaria
• Emergency treatment of malaria in children and low body weight patients
• Pre-referral treatment before transfer to a higher care facility
• Malaria caused by Plasmodium falciparum infection

Gen-M Injection 60mg Benefits

• Works faster than quinine in reducing parasite count
• Suitable for children and patients with low body weight
• Can be given by IV or IM injection when oral treatment is not possible
• Reduces risk of death in severe malaria cases
• Effective against multi drug resistant malaria strains

What Experts Say

Doctors regard intravenous artesunate as the preferred first line treatment for severe malaria because it clears parasites from the blood faster than quinine and lowers the risk of death in critical cases. The World Health Organization recommends artesunate injection over quinine for both adults and children with severe disease.

The 60mg strength is specifically formulated for children and patients with lower body weight, since dosing is calculated per kilogram rather than as a fixed adult amount. Physicians monitor patients closely for several weeks after treatment because delayed hemolysis, a drop in red blood cells, can occur even after the fever and parasites clear.

Malaria remains a genuine public health concern in Pakistan, particularly during monsoon season when mosquito breeding increases sharply. Physicians recommend that every patient completes a full course of oral artemisinin combination therapy after the injectable course, since artesunate alone given for a short period is not sufficient to fully clear the infection and prevent relapse.

Drug Class

• Antimalarial
• Artemisinin derivative

Gen-M injection 60mg formula

• Artesunate

Available forms

• Injection

How to use Gen-M injection 60mg?

• Administered only by a doctor or trained healthcare professional in a hospital setting
• Given as a slow intravenous or intramuscular injection, never self administered
• Dose is calculated based on the patient's body weight in kilograms
• Usually given at 0, 12, and 24 hours, then once daily for up to 7 days as needed
• Followed by a complete course of oral artemisinin combination therapy after the injectable doses

Drug Interactions

• Mefloquine: Combined use may increase the risk of neurological side effects and requires close monitoring.
• Quinine: Using both together is generally avoided since it increases the risk of cardiac side effects.
• Other Antimalarials: Concurrent use of another artemisinin based drug is not recommended outside of standard combination therapy.
• Hepatotoxic Drugs: Combining with other drugs that affect the liver may increase strain on liver function.

Risks and warnings

• Hemolysis Risk: Delayed breakdown of red blood cells can occur up to several weeks after treatment, requiring follow up blood tests.
• Hypersensitivity: Rare allergic reactions including rash, itching or swelling can occur during or after the infusion.
• Pregnancy Caution: Use only if the benefit clearly outweighs risk, especially in the first trimester, and only under medical supervision.
• Neurological Effects: Rare cases of dizziness or hearing changes have been reported with high doses.
• Injection Site Reactions: Pain, swelling or irritation may occur at the injection site.

Gen-M Injection 60mg Side Effects

• Fever
• Headache
• Dizziness
• Nausea and vomiting
• Loss of appetite
• Injection site pain or swelling
• Delayed anemia or hemolysis
• Mild elevation in liver enzymes
• Cough
• Skin rash

Storage Conditions

• Store below 25°C in a cool, dry place away from direct sunlight
• Keep the vial in its original packaging until ready to use
• Reconstituted solution should be used immediately and not stored for later use
• Do not freeze
• Keep out of reach of children